financetom
Business
financetom
/
Business
/
Update: GreenFirst Forest Products Narrows Q4 Loss, Net Sales Rise; Cuts Board Size; Down 5.4%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: GreenFirst Forest Products Narrows Q4 Loss, Net Sales Rise; Cuts Board Size; Down 5.4%
Mar 15, 2024 11:25 AM

01:55 PM EDT, 03/15/2024 (MT Newswires) -- GreenFirst Forest Products Inc. ( ICLTF ) overnight Thursday reported a fourth-quarter net loss of $21.6 million, or $0.12 per diluted share, narrower than a loss of $43.6 million, or $0.25 per diluted share, a year earlier.

Total net sales from continuing operations for the quarter ended Dec. 31, 2023, were $103.2 million, up from $100.2 million a year earlier.

Adjusted EBITDA loss from continuing operations for Q4 was $18 million, down from a loss of $27.4 million a year earlier.

The board hass agreed to reduce its size to five directors at the next annual general meeting of shareholders on April 19. Barbara Anie, Sean Willy, and Candice Bergen have voluntarily decided not to stand for re-election at the AGM.

Anie and Willy will continue to the AGM and Bergen has resigned.

The reduction is part of efforts to align with the reduced size and location of GreenFirst's operations, the company said.

The company's stock dropped 5.4% on last look on Friday.

Price: 0.70, Change: -0.04, Percent Change: -5.41

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Soccer-Man Utd's Mazraoui undergoes heart procedure, expected to return in next few weeks
Soccer-Man Utd's Mazraoui undergoes heart procedure, expected to return in next few weeks
Oct 10, 2024
MANCHESTER, England, Oct 10 (Reuters) - Manchester United ( MANU ) defender Noussair Mazraoui has undergone a corrective heart procedure after experiencing palpitations but is expected to be available to play in the next few weeks, according to team sources. Mazraoui withdrew on Monday from the Morocco squad for two Africa Cup of Nations qualifiers against the Central African Republic...
What's Going On With Pfizer Stock On Thursday?
What's Going On With Pfizer Stock On Thursday?
Oct 10, 2024
On Thursday, Starboard Value LP, a significant shareholder of Pfizer Inc. ( PFE ) , issued a letter to the company’s Board of Directors. Starboard Value said they had scheduled a meeting with CEO Albert Bourla, Shantanu Narayen, and potentially other Board members on October 16. They plan to share their perspectives and discuss Pfizer’s future direction. Also Read: Former...
Nordson Insider Sold Shares Worth $749,940, According to a Recent SEC Filing
Nordson Insider Sold Shares Worth $749,940, According to a Recent SEC Filing
Oct 10, 2024
10:43 AM EDT, 10/10/2024 (MT Newswires) -- Joseph P Kelley, Executive Vice President, on October 09, 2024, sold 3,000 shares in Nordson ( NDSN ) for $749,940. Following the Form 4 filing with the SEC, Kelley has control over a total of 8,659 shares of the company, with 8,659 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/72331/000007233124000113/xslF345X05/wk-form4_1728571106.xml Price: 251.72, Change: -1.47, Percent...
Abbott Completes Study Enrolment for Heart Rhythm Treatment Device, Launches New Heart Mapping Technology
Abbott Completes Study Enrolment for Heart Rhythm Treatment Device, Launches New Heart Mapping Technology
Oct 10, 2024
10:45 AM EDT, 10/10/2024 (MT Newswires) -- Abbott Laboratories ( ABT ) said Thursday it has completed enrolment of nearly 400 patients in the global investigational device exemption study for its abnormal heart rhythm treatment Volt Pulsed Field Ablation system in three months, which is ahead of schedule. The global FOCALFLEX trial is also underway to evaluate Abbott's TactiFlex Duo...
Copyright 2023-2026 - www.financetom.com All Rights Reserved